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Abstract: Several reactive sites of 1,2- and 1,3-ketoamides 
were successively exploited in two complementary domino 
transformations for the synthesis of either polysubstituted 
mono cyclic or bridged bicyclic cyclohexanes with the creation 
of up to six stereogenic centers. In both cases, a chiral 
bifunctional thiourea organocatalyst allowed an efficient 
control of the chirality in the final carbocycles. 
Keywords: Enantioselective organocatalysis, Domino 
reactions, Ketoamides, Cyclohexanes, Bifunctional thioureas 
Introduction 
The development of domino enantioselective 
organocatalytic methodologies has received an intense 
research attention attested by the high number of 
recent reports directed to the stereoselective 
construction of heterocylic and carbocyclic scaffolds.
1
 
Among these, substituted chiral cyclohexanes are 
important building blocks in organic synthesis,
2
 and 
many of these approaches have allowed the control of 
the relative and absolute configurations in the 
construction of these versatile molecular 
architectures.
3,4
 These methods have the advantage of 
assembling efficiently the desired target from easily 
accessible starting materials along with the creation 
and control of multiple stereogenic carbon atoms. 
Most of these strategies employ simple substrates with 
multiple reactive sites that are involved successively 
in the formation of carbon–carbon and/or carbon–
heteroatom bonds. In this context, dicarbonyl 
compounds and more particularly ketoamides are 
attractive substrates given the high density of potential 
reactive sites and thus, they are well suited for 
designing new stereoselective domino transformations 
for the asymmetric synthesis of functionalized six-
membered carbocycles.
5
 
Results and discussion 
We have recently shown that 1,2- and 1,3-ketoamides 
1 and 4 could be specifically activated using a 
thiourea-tertiary amine bifunctional organocatalyst 
and consequently, we successfully developed 
enantioselective Michael additions with these 
substrates and either nitroalkenes 2 or !,"-unsaturated 
carbonyls 5 as the electrophilic partners.
6
 We now 
wish to exploit this work and the Michael adducts 3 
and 6 as versatile synthetic platforms in subsequent 
transformations leading to more complex molecular 
frameworks, such as substituted cyclohexanes 
(Scheme 1). 
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Scheme 1. Access to optically active six-membered carbocycles from 
1,2- and 1,3-ketoamides 1 and 4 
 
In the case of 1,2-ketoamides 1, and once the Michael 
adduct 3 is formed (Scheme 2), we reasoned that the 
addition of a second equivalent of nitroalkene could 
trigger another conjugate addition leading to 
intermediate 7. The latter should then undergo an 
intramolecular Henry reaction, terminating the 
domino transformation and affording the desired 
hexasubstituted cyclohexane 8.
7
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Scheme 2. Strategy for the synthesis of hexasubstituted cyclohexanes 8 
We started our investigations by screening various 
bifunctional organocatalysts I-IV bearing either 
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thiourea or squaramide hydrogen-bond donor subunits 
(Table 1). While catalyst I derived from cinchonine 
allowed only the formation of 8a as traces (entry 1, 
the sequence stopped at the Michael adduct stage), we 
were very pleased to find that Takemoto's catalyst II 
(R,R-TUC)
8
 was efficient for this domino 
transformation, affording 8a in good yield (67%) with 
very good diastereo- and enantiomeric ratios (>20:1 
and 28:1 respectively, entry 2). Remarkably, one out 
of the 64 possible stereoisomers was obtained 
predominantly. The use of catalysts III and IV with a 
squaramide subunit gave poor results (entries 3 and 4) 
and only trace amounts of cyclohexane 8a were 
formed (<5%). The highest yield and 
stereoselectivities were obtained in ethyl acetate 
(entry 2) and switching to dichloromethane led to the 
formation of the desired product in lower yield and 
selectivities (entry 5). Other solvents such as DMSO 
and MTBE were not suitable, leading to 
decomposition and poor reactivity, respectively. 
(entries 6 and 7). 
Table 1. Optimization of the domino Michael–Michael–Henrya 
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O
H
N
O
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+
R2
NO2
1a (R1 = CH3) 2a (R2 = 4-FC6H4)
cat* I-IV
(10 mol%)
Ar = 3,5-(CF3)2C6H3
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Entry Catalyst Solvent Yield of 8a
b
 dr
c
  er
d
 
1 I EtOAc <5% n.d. n.d. 
2 II EtOAc 62% >20:1 28:1 
3 III EtOAc <5% n.d. n.d. 
4 IV EtOAc <5% n.d. n.d. 
5 II CH2Cl2 45% 1:1.5 n.d. 
6 II DMSO decomposition - - 
7 II MTBE <5% n.d. n.d. 
a
All reactions were run using 0.2 mmol of 1a, 0.42 mmol of 2a in 0.4 
mL of solvent. 
b
Yields of analytically pure isolated products. 
c
Diastereomeric ratios were determined by 
1
H NMR spectroscopy 
analysis of the crude reaction mixtures. 
d
Enantiomeric ratio was 
determined by HPLC analysis on a chiral stationary phase. 
 
After optimizing the reaction conditions, we studied 
the possibility of using different ketoamides 1 as well 
as different nitroalkenes 2 to synthesize various 
hexasubstituted cyclohexane derivatives 8a-e (Scheme 
3). Hence, using Takemoto’s catalyst II, in ethyl 
acetate at room temperature for four days, we were 
delighted to found that the cyclohexanes 8 were 
obtained in fair yields but most importantly with 
generally very good stereoselectivities. Electron-
withdrawing as well as electron-donating groups on 
the aryl substituent of the ketoamide 1 were well 
tolerated in this reaction, although the use of 
ketoamide 1c (R
1
 = Et, Ar = 2,5-Cl2C6H3) bearing a 
sterically demanding 2,5-dichlorophenyl substituent 
had a negative impact on the enantioselectivity of the 
domino reaction (8c, e.r. = 4:1). Concerning the 
nitroalkene partner 2, both phenyl- and p-
fluorophenylnitroalkenes are suitable substrates for 
this reaction. 
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Scheme 3. Scope of the Michael–Michael–Henry reaction leading to 8 
 
Our earlier studies had shown that Takemoto's catalyst 
II was also efficient to promote the enantioselective 
Michael addition of 1,3-ketoamides 4 to !,"-
unsaturated carbonyls.
6b
 When acrolein 9 is used as 
the electrophilic reaction partner, two modes of 
cyclization can be envisaged for the initial adducts 6 
(Scheme 4). The first one is the formation of 
hemiaminal 10, which we already exploited (path a). 
The second one may involve an intramolecular aldol 
reaction, leading directly to a bicyclo[3.2.1]octane 11 
that bears a bridged six-membered ring with three 
stereogenic centers (path b). Given the prevalence of 
this skeleton in natural products and the challenge 
associated with their synthesis,
9
 new modular 
enantioselective accesses are of high synthetic 
interest. 
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Scheme 4. Diverging pathways for the cyclization of the adducts of 
1,3-ketoamides with acrolein 
 
In our initial study with N-tosylketoamide, the 
hemiaminal was obtained as the sole product.
6b
 
However, when we tried to extend this reactivity to N-
arylketoamide 4a, a spontaneous evolution towards a 
mixture of both products 10a and 11a was observed 
(Table 2), indicating that an equilibrium exists 
between compounds 10a, which is the kinetic product, 
and 11a, which is the thermodynamic one. At –20 °C 
in the presence of catalyst II, after 48 h at room 
temperature a 3.5:1 ratio between products 10a and 
11a with the hydroxyl group in axial position was 
obtained (Entry 1). To favor the formation of the 
bicyclic product, different reaction conditions were 
investigated after the completion of the Michael 
addition. At room temperature, without the addition of 
any other reagent, a slow evolution was observed to 
reach a 1.5:1 ratio after an additional two days stirring 
(Entry 2). We could verify that Takemoto's catalyst II 
was really involved in this process as no 
interconversion between the products was obtained in 
its absence. As expected, increasing the temperature to 
60 °C led to the formation of 11a as major compound 
with a 12:1 dr and a 4.7:1 er (Entry 3). We then 
looked for other additives that could affect the 
thermodynamic interconversion of 10a to 11a. While 
the addition of a catalytic amount of L-proline V had 
limited impact (Entry 4), stoichiometric amounts of N-
heterocyclic carbene IPr VI (Entry 5)
10
 and 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) VII (Entry 6) 
completely shifted the equilibrium towards the desired 
product 11a, albeit with very modest 
diastereoselectivities. In the last case, the er of the 
major diastereomer amounted to 5.1:1. 
 
Table 2. Optimization of the reaction conditions for the synthesis of 
bicyclo[3.2.1]octane 11aa 
O
N
H
O
+
O
H
2) conditions
4a
N
O
OH
O
10a
11a
1) cat* II (10 mol%)
toluene, -35 °C, 48 h
NO2
NO2
+
O
HO
OHN
NO2
N
H
CO2H
V
N N
VI
N
N
VII
 
Entry conditions ratio 
10a/11a
b
 
dr 
(OHax/OHeq)
c
 
er
d
 
1 -
e
 3.5:1 >20:1 n.d. 
2 r.t., 2 d 1.5:1 >20:1 n.d. 
3 60 °C, 2 d 1:9.3 12:1 4.7:1 
4 V (20 mol%), 
r.t., 2 d 
1:1.1 >20:1 n.d. 
5 VI (1.1 equiv), 
r.t., 3 d 
<1:20 1:2 n.d. 
6 VII (1 equiv), 
r.t., 10 min 
<1:20
f
 1.4:1 4.1:1 
and 
3.7:1 
a
All reactions were run using 0.2 mmol of 4a, 0.4 mmol of 9 in 4 mL 
of solvent. 
b
Determined by 
1
H NMR spectroscopy analysis of the 
crude reaction mixtures. 
c
Diastereomeric ratios were determined by 
1
H 
NMR spectroscopy analysis of the crude reaction mixtures. 
d
Enantiomeric ratio of the major diastereomer of 11a (OH in axial 
position) was determined by HPLC analysis on a chiral stationary 
phase. 
e
Analyses conducted directly at the end of the Michael addition 
step. 
f
 82% yield after purification. 
 
DBU was selected as the best promoter for the 
isomerization because it allowed an efficient reaction 
with a short reaction time and we investigated the 
behavior of other 1,3-ketoamides
11
 when submitted to 
these reaction conditions (Scheme 5). With other N-
aryl-1,3-ketoamides 4b and 4c, we noticed that an 
evaporation of the excess acrolein was required prior 
to DBU addition in order to avoid a double Michael 
addition. Products 11b and 11c were obtained with 
reasonable yields but moderate stereoselectivities. 
Interestingly, N-aryl-1,3-ketoamides 4d could also be 
converted into the bicyclic product 11d. Because of 
the higher stability of the hemiaminal in this case, the 
isomerization with DBU had to be conducted at 60 °C. 
Once again, there was no diastereoselectivity but high 
enantioselectivities (66:1 and 14:1 er respectively) 
were obtained for both diastereomers. The differences 
in enantiomeric ratios observed between the different 
cyclization modes
12
 clearly indicate that these 
compounds are prone to racemization. As a result, 
particular care must be taken during the reaction and 
post functionalization to avoid such an issue. 
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Scheme 5. Scope study of the formation of bicyclo[3.2.1]octanes 11 
 
Bicyclic alcool 11d could also be derivatized with 
success by IBX oxidation in refluxing ethyl acetate, 
quantitatively generating the 
bicyclo[3.2.1]octanedione 12 (Scheme 6). Most 
importantly, an excellent 24:1 er was observed for the 
formation of this valuable structure. 
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Scheme 6. Scope study of the formation of bicyclo[3.2.1]octanes 11 
Conclusion 
We have demonstrated that 1,2- and 1,3-ketoamides 
could be specifically activated with thiourea 
organocatalysts and used in domino transformations 
for the enantioselective synthesis of polysubstituted 
cyclohexanes. In the case of 1,2-ketoamides, we 
exploited both their pronucleophilic character,
13
 and 
the ketone moiety as electrophile site for the synthesis 
of hexasusbtituted cyclohexanes by reaction with 
nitroalkenes partners. Amazingly, one out of 64 
stereoisomers was formed almost exclusively. 
Alternatively, 1,3-ketoamides where used as efficient 
C-bisnucleophiles with acroleine as the electrophilic 
partner allowing access to bicyclo[3.2.1]octanes in the 
optically active form with the formation of two new 
C–C bonds and three stereogenic carbon atoms. 
Further studies are currently undertaken in our 
laboratory in order to extend the scope of these 
promising cascade reactions. 
Experimental section 
All reagents were obtained from commercial sources 
and used as supplied unless otherwise stated. NMR 
data were recorded on a Bruker Avance 400 
spectrometer in CDCl3 and chemical shifts (!) are 
given in ppm relative to the residual non-deutered 
solvent signal for 
1
H NMR (CHCl3: 7.26 ppm), and 
relative to the deutered solvent signal for 
13
C NMR 
(CDCl3: 77.16 ppm); coupling constants (J) are in 
Hertz, and the classical abbreviations are used to 
describe the signal multiplicity. High-resolution mass 
spectra were obtained from the Spectropole 
(http://www.spectropole.u-3mrs.fr/). Optical rotations 
were measured with a PERKIN ELMER 241 
micropolarimeter. Melting points (mp) were 
determined with a Büchi Melting-point B-450 
apparatus and were not corrected. Thin layer 
chromatography (TLCs) were developed on silica 
Merck 60F254. Visualization was achieved under a 
UVP mineralight UVGL-58 lamp, and by developing 
the plates with phosphomolybdic acid and p-
anisaldehyde reagents. The products were purified by 
flash column chromatography on silica gel 60 (Merck 
1.09386.9025, 230-400 mesh).  
General procedure for the synthesis of 
cyclohexanes 8 
1,2-ketoamides 1 (1.00 equiv), nitroalkenes 2 (2.10 
equiv) and thiourea-catalyst II (0.10 equiv) were 
successively added as solid in a sealed tube and 
dissolved in ethyl acetate (0.5 M). After 96 hours of 
reaction time at room temperature, the solvent was 
evaporated and the crude product was purified by 
flash chromatography on silica gel (eluent: ethyl 
acetate/petroleum ether, 30:70 then 50:50). The 
diastereomeric ratio (dr) was determined by 
1
H NMR 
spectroscopy analysis of the crude product and the 
enantiomeric ratio (er) was determined by HPLC 
analysis on a chiral stationary phase. 
 
8a: this product was synthesized starting from 1a (R
1
 
= Me, Ar = Ph, 36 mg, 0.2 mmol) and 2a (R
2
 = 4-
FC6H4, 70 mg, 0.42 mmol) according to the above 
procedure and was obtained as a white solid (63 mg, 
62%). Rf (EA/PE, 3:7) = 0.30; mp = 181-182 °C; !D
30
 
(CH2Cl2, c = 1.0) = –22.3; Chiral HPLC (ChiralPak 
AD-H, hexane/iPrOH = 9:1, flow rate = 1.0 mL/min, 
# = 306 nm): tminor = 24.7 min, tmajor = 28.0 min, er = 
99:1; 
1
H NMR  (400 MHz, CD2Cl2): # 8.65 (brs, 1H, 
NH), 7.62 (br s, 2H), 7.52 (d, J = 8.0 Hz, 2H), 7.42-
7.36 (m, 4H), 7.20 (d, J = 8.0 Hz, 1H), 7.08 (d, J = 8.0 
Hz, 2H), 7.02 (d, J = 8.0 Hz, 2H, ArH), 5.76 (d, J = 
12.0 Hz, 1H), 5.60 (dd, J = 12.0, 7.2 Hz, 1H), 4.61 
(dd,  J = 12.0, 12.0 Hz, 1H), 4.61 (s, 1H, OH), 4.00 
(dd, J = 7.2, 7.2 Hz, 1H), 3.05–2.99 (m, 1H), 0.98 (d, 
J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CD2Cl2): $ 
169.1, 163.4 (d, J = 248 Hz), 163.3 (d, J = 248 Hz), 
138.8 (d, J = 8 Hz, 2C), 136.7 (2C), 130.5 (d, J = 8 
Hz, 2C), 129.9 (d, J = 4 Hz),  129.7, 129.5 (d, J = 4 
Hz), 126.1, 120.7 (2C), 116.8 (d, J = 17 Hz, 2C), 
115.7 (d, J = 17 Hz, 2C), 92.0, 89.3, 80.1, 49.7, 42.2, 
39.3, 14.0; HRMS (ES+): m/z calcd for 
[(C26H24F2N3O6+H)
+
]: 512.1628; found: 512.1619. 
8b: this product was synthesized starting from 1b (R
1
 
= Et, Ar = 4-ClC6H4, 45 mg, 0.2 mmol) and 2a (R
2
 = 
4-FC6H4, 70 mg, 0.42 mmol) according to the above 
procedure and was obtained as a white solid (57 mg, 
51%). mp 248 °C (dec.). Rf (EA/PE, 1:4) = 0.30; Chiral 
HPLC (ChiralPak IA, hexane/ethanol/chloroforme = 
5:3:2, flow rate = 1.0 mL/min, # = 254 nm): tminor = 
4.0 min, tmajor = 5.8 min, er = 19:1;
 1
H NMR  (400 
MHz, CD2Cl2): # 8.68 (brs, 1H, NH), 7.70 (br s, 2H), 
7.50 (d, J = 8.9 Hz, 2H), 7.37-7.31 (m, 4H), 7.08 (d, J 
= 8.9 Hz, 2H), 7.03 (d, J = 8.9 Hz, 2H), 5.61 (d, J = 
12.5 Hz, 1H), 5.43 (dd, J = 12.5, 6.9 Hz, 1H), 4.65 (s, 
1H, OH), 4.45 (dd, J = 12.5, 12.5 Hz, 1H), 4.16 (dd, J 
= 6.9, 6.9 Hz, 1H), 2.75-2.70 (m, 1H), 1.44-1.33 (m, 
2H), 0.87 (d, J = 7.3 Hz, 3H);
 13
C NMR (100 MHz, 
CD2Cl2): $ 169.3, 163.2 (d, J = 248 Hz), 163.1 (d, J = 
248 Hz), 135.3, 133.8 (d, J = 8 Hz, 2C), 130.9, 130.4 
(d, J = 8 Hz, 2C), 129.7 (d, J = 4 Hz),  129.6 (2C), 
129.0 (d, J = 4 Hz), 121.9 (2C), 116.7 (d, J = 22 Hz, 
2C), 115.8 (d, J = 22 Hz, 2C), 92.1, 89.8, 80.2, 46.7, 
46.1, 41.6, 20.8, 12.0; MS (ES+): m/z [(M+Na)
+
] 582; 
HRMS (ES+): m/z calcd for [(C27H24N3O6ClF2+H)
+
]: 
560.1394; found: 560.1395. 
 
8c: this product was synthesized starting from 1c (R
1
 
= Et, Ar = 2,5-Cl2C6H3, 52 mg, 0.2 mmol) and 2a (R
2
 
= 4-FC6H4, 70 mg, 0.42 mmol) according to the above 
procedure and was obtained as a white solid (57 mg, 
47%). Rf (EA/PE, 1:4) = 0.41; mp = 203-205 °C; !D
22
 
(CH2Cl2, c = 0.52) = –12.9; Chiral HPLC (ChiralPak 
IA, hexane/ethanol/chloroforme = 3:1:1, flow rate = 
1.0 mL/min, # = 254 nm): tminor = 4.1 min, tmajor = 5.8 
min, er = 4 : 1; 
1
H NMR (400 MHz, CD2Cl2): # 9.21 
(brs, 1H, NH), 8.35 (brs, 1H), 7.72-7.69 (m, 2H), 
7.38-7.34 (m, 4H), 7.14-7.04 (m, 5H), 5.56 (d, J = 
12.5 Hz, 1H), 5.39 (dd, J = 12.5, 6.8 Hz, 1H), 4.72 (s, 
1H, OH), 4.46 (dd,  J = 12.5, 12.5 Hz, 1H), 4.17 (dd, J 
= 6.8, 6.8 Hz, 1H), 2.72-2.67 (m, 1H), 1.55-1.37 (m, 
2H), 0.88 (d, J = 7.3 Hz, 3H); 
13
C NMR (100 MHz, 
CD2Cl2): $ 169.5, 163.3 (d, J = 248 Hz), 163.2 (d, J = 
248 Hz), 134.4, 133.8 (d, J = 8 Hz, 2C), 130.5 (2C), 
130.4 (d, J = 8 Hz), 129.6 (d, J = 4 Hz), 128.9 (d, J = 
4 Hz), 126.4, 122.6, 121.8, 116.7 (d, J = 22 Hz, 2C), 
115.9 (d, J = 22 Hz, 2C), 92.1, 89.8, 80.5, 46.7, 46.2, 
41.6, 20.7, 12.0; MS (ES+): m/z [(M+Na)
+
] 616; 
HRMS (ES+): m/z calcd for [(C27H23N3O6Cl2F2+H)
+
]: 
594.1005; found: 594.1003. 
8d: this product was synthesized starting from 1d (R
1
 
= Et, Ar = 4-MeOC6H4, 44 mg, 0.2 mmol) and 2a (R
2
 
= 4-FC6H4, 70 mg, 0.42 mmol) according to the above 
procedure and was obtained as a white solid (74 mg, 
67%). Rf (EA/PE, 1:4) = 0.11; mp = 109-111 °C; !D
30
 
(CH2Cl2, 0.57) = +29.5; Chiral HPLC (ChiralPak IB, 
hexane/ethanol = 4:1, flow rate = 1.0 mL/min, # = 254 
nm): tminor = 10.9 min, tmajor = 6.6 min, er = 28:1; 
1
H 
NMR (400 MHz, CD2Cl2): # 8.60 (brs, 1H, NH), 
7.69-7.66 (m, 2H), 7.41 (d, J = 9.0 Hz, 2H), 7.34-7.30 
(m, 2H), 7.05 (d, J = 9.0 Hz, 2H), 6.96 (d, J = 9.0 Hz, 
2H), 6.88 (d, J = 9.0 Hz, 2H), 5.70 (d, J = 12.3 Hz, 
1H), 5.50 (dd, J = 12.3, 6.9 Hz, 1H), 4.69 (s, 1H, OH), 
4.41 (dd, J = 12.3, 12.3 Hz, 1H), 4.11 (dd, J = 6.9, 6.9 
Hz, 1H), 2.82-2.76 (m, 1H), 1.47-1.36 (m, 2H), 0.87 
(d, J = 7.3 Hz, 3H); 
13
C NMR (100 MHz, CD2Cl2): $ 
168.7, 162.8 (d, J = 248 Hz), 162.7 (d, J = 248 Hz), 
157.5, 133.2 (d, J = 8 Hz, 2C), 129.9 (d, J = 8 Hz, 
2C), 129.0 (d, J = 4 Hz), 128.9, 128.5 (d, J = 4 Hz), 
122.0 (2C), 116.3 (d, J = 22 Hz, 2C), 115.6 (d, J = 22 
Hz, 2C), 114.4 (2C), 91.7, 89.3, 79.7, 55.5, 46.4, 45.5, 
41.2, 20.3, 11.8; MS (ES+): m/z [(M+Na)
+
] 579; 
HRMS (ES+): m/z calcd for [(C28H27N3O7F2+H)
+
]: 
556.1890; found: 556.1889. 
 
8e: this product was synthesized starting from 1d (R
1
 
= Et, Ar = 4-MeOC6H4, 44 mg, 0.2 mmol) and 2b (R
2
 
= C6H5, 63 mg, 0.42 mmol) according to the above 
procedure and was obtained as a white solid (55 mg, 
53%). Rf (EtOAc/PE, 1:4) = 0.18; mp = 139-141 °C; 
!D
22
 (CH2Cl2, c = 9.9) = +9.7; Chiral HPLC 
(ChiralPak IB, exane/ethanol = 7:3, flow rate = 1.0 
mL/min, # = 254 nm): tminor = 6.6 min, tmajor = 5.3 min, 
er = 28:1; 
1
H NMR (400 MHz, CDCl3): # 8.59 (brs, 
1H, NH), 7.69 (br s, 2H), 7.40-7.36 (m, 8H), 7.34-
7.28 (m, 2H), 6.86 (d, J = 9.0 Hz, 2H), 5.69 (d, J = 
12.5 Hz, 1H), 5.48 (dd, J = 12.5, 6.7 Hz, 1H), 4.54 
(dd, J = 12.5, 12.5 Hz, 1H), 4.52 (s, 1H, OH), 4.13 
(dd, J = 6.7, 6.7 Hz, 1H), 3.77 (s, 3H), 2.81-2.76 (m, 
1H), 1.45-1.37 (m, 2H), 0.91 (d, J = 7.3 Hz, 3H);
13
C 
NMR (100 MHz, CDCl3): $ 168.8, 157.3, 133.7, 
132.9 (2C), 131.3 (2C), 129.2 (2C), 129.0, 128.7 (2C), 
128.6, 128.2 (2C), 122.0 (2C), 114.3 (2C), 92.0, 89.4, 
79.7, 55.5, 47.0, 45.7, 41.9, 20.4, 11.9. MS (ES+): m/z 
[(M+Na)
+
] 542; HRMS (ES+): m/z calcd for 
[(C28H29N3O7+H)
+
]: 520.2078; found: 520.2077. 
 
General procedure for the synthesis of 
bicyclo[3.2.1]octanes 11 
A solution of 1,3-ketoamides 4 (0.2 mmol, 1 equiv) 
and thiourea-catalyst II (0.02 mmol, 0.1 equiv.) in dry 
toluene (4 mL) was cooled at –35°C. Acrolein 9 (27 
%L, 0.4 mmol, 2 equiv) was added and the mixture 
was stirred for 24-48 hours until full conversion of 4. 
Then DBU (30 %L, 0.2 mmol, 1 equiv.) was added to 
the reaction medium, which was subsequently 
warmed to room temperature and stirred for 1 hour. 
The mixture was concentrated under reduced pressure. 
HCl (1N) was added and the mixture was extracted 
twice with CH2Cl2. The combined organic phase was 
washed with brine, dried over anhydrous Na2SO4 and 
evaporated under reduced pressure. The crude product 
was purified by flash column chromatography (ethyl 
acetate/petroleum ether) to afford pure 11. 
 
11a: this product was synthesized starting from 4a (R 
= 4-NO2C6H4, 50 mg, 0.2 mmol) according to the 
above procedure and was obtained as a 1.4:1 mixture 
of diastereomers as a pale yellow solid (50 mg, 82%). 
Rf (EA/CH2Cl2, 2:3) = 0.33; mp = 137-139 °C; Chiral 
HPLC (Lux-Amylose-2, hexane/iPrOH = 7:3, flow 
rate = 1.0 mL/min, # = 220 nm): diastereomer OHax: 
tminor = 18.0 min, tmajor = 21.0 min, er = 4.1:1, 
diastereomer OHeq: tminor = 10.1 min, tmajor = 11.3 min, 
er = 3.7:1; 
1
H NMR (400 MHz, CDCl3): diastereomer 
OHax: # 10.21 (s, NH), 8.21 (d, J = 9.2 Hz, 2H), 7.77 
(d, J = 9.2 Hz, 2H), 4.45 (s, 1H), 2.67 (dd, J = 7.1, 5.4 
Hz, 1H), 2.46-2.40 (m, 1H), 2.39-2.31 (m, 2H), 2.31-
2.12 (m, 2H), 2.03-1.92 (m, 1H), 1.84-1.71 (m, 2H), 
diastereomer OHeq: # 10.07 (s, NH), 8.21 (d, J = 9.2 
Hz, 2H), 7.77 (d, J = 9.2 Hz, 2H), 4.14 (br s, 1H), 2.75 
(dd, J = 7.0, 3.1 Hz, 1H), 2.46-2.40 (m, 1H), 2.39-2.31 
(m, 2H), 2.31-2.12 (m, 2H), 2.03-1.92 (m, 1H), 1.84-
1.71 (m, 2H). 
13
C NMR (75 MHz, DMSO-d6): 
diastereomer OHax: $ 213.0, 171.0, 145.42, 142.21, 
124.88 (2C), 119.3 (2C), 76.9, 57.5, 52.3, 34.1, 26.6, 
25.4, 18.9, diastereomer OHeq: # 213.1, 170.7, 145.36, 
142.23, 124.94 (2C), 119.2 (2C), 73.6, 57.7, 54.8, 
31.8, 28.2, 26.4, 16.3; MS (ES+): m/z [(M+Na)
+
] 327; 
HRMS (ES+): m/z calcd for [(C15H16N2O5+H)
+
]: 
305.1132; found: 305.1130. 
 
11b: this product was synthesized starting from 4b (R 
= C6H5, 41 mg, 0.2 mmol) by adapting the above 
procedure. After full conversion of 4b, the excess of 
acrolein was eliminated by reduced pressure (100 
mbar), without evaporation of toluene. Then DBU 
was added and the reaction mixture was stirred at 
room temperature for 1 hour to afford 11b as a 1:1.2 
mixture of diastereomers as a colorless viscous liquid 
(38 mg, 73%). Rf (EA/CH2Cl2, 2:3) = 0.28; Chiral 
HPLC (Chiralcel OD-3, hexane/iPrOH = 9:1, flow 
rate = 1.0 mL/min, # = 254 nm): diastereomer OHax: 
tminor = 18.9 min, tmajor = 23.0 min, er = 4.8:1, 
diastereomer OHeq: tminor = 17.0 min, tmajor = 20.4 min, 
er = 4.9:1; 
1
H NMR (400 MHz, CDCl3): diastereomer 
OHax: # 9.79 (s, NH), 7.60-7.51 (m, 2H), 7.32 (t, J = 
7.9 Hz, 2H), 7.10 (td, J = 7.3, 1.2 Hz, 1H), 4.42-4.30 
(m, 1H), 2.64-2.57 (m, 1H), 2.44-2.19 (m, 4H), 2.16-
1.99 (m, 1H), 1.96-1.64 (m, 3H), diastereomer OHeq: 
# 9.67 (s, NH), 7.60-7.51 (m, 2H), 7.32 (t, J = 7.9 Hz, 
2H), 7.10 (td, J = 7.3, 1.2 Hz, 1H), 4.18-4.03 (m, 1H), 
2.72 (dd, J = 6.9, 3.2 Hz, 1H), 2.44-2.19 (m, 3H), 
2.16-1.99 (m, 2H), 1.96-1.64 (m, 3H). 
13
C NMR (75 
MHz, CDCl3): diastereomer OHax: $ 217.9, 170.0, 
137.7, 129.1 (2C), 124.5, 120.3 (2C), 78.5, 54.4, 53.2, 
38.5, 26.3, 25.8, 18.6, diastereomer OHeq: # 216.9, 
169.9, 137.6, 129.1 (2C), 124.6, 120.3 (2C), 74.7, 
55.2, 53.9, 35.6, 27.5, 26.7, 15.5. MS (ES
+
): m/z 
[(M+Na)
+
] 282; HRMS (ES+): m/z calcd for 
[(C15H17NO3+H)
+
]: 260.1281; found: 260.1284. 
 
11c: this product was synthesized starting from 4c (R 
= 1-naphthyl, 51 mg, 0.2 mmol) by adapting the above 
procedure. After full conversion of 4c, the excess of 
acrolein was eliminated by reduced pressure (100 
mbar), without evaporation of toluene. Then DBU 
was added and the reaction mixture was stirred at 
room temperature for 1 hour to afford 11c as a 1:1.2 
mixture of diastereomers as a viscous liquid (38 mg, 
62%). Rf (EA/CH2Cl2, 2:3) = 0.30; Chiral HPLC 
(Lux-Amylose-2, hexane/iPrOH = 7:3, flow rate = 1.0 
mL/min, # = 254 nm): diastereomer OHax: tminor = 10.2 
min, tmajor = 33.5 min, er = 7.5:1, diastereomer OHeq: 
tminor = 6.9 min, tmajor = 7.9 min, er = 8.0:1; 
1
H NMR 
(400 MHz, CDCl3): diastereomer OHax: # 10.38 (s, 
NH), 8.18-8.12 (m, 2H), 7.86 (d, J = 7.7 Hz, 1H), 7.67 
(d, J = 8.2 Hz, 1H), 7.61-7.55 (m, 1H), 7.54-7.44 (m, 
2H), 4.41-4.30 (m, 1H), 2.64 (dd, J = 7.1, 5.2 Hz, 1H), 
2.55-2.21 (m, 4H), 2.20-2.07 (m, 1H), 1.88-1.65 (m, 
3H), diastereomer OHeq: # 10.24 (s, NH), 8.18-8.12 
(m, 1H), 8.09 (d, J = 8.4 Hz, 1H), 7.87 (d, J = 7.8 Hz, 
1H), 7.67 (d, J = 8.2 Hz, 1H), 7.61-7.55 (m, 1H), 
7.54-7.44 (m, 2H), 4.17-4.04 (m, 1H), 2.76 (dd, J = 
6.9, 3.2 Hz, 1H), 2.55-2.21 (m, 3H), 2.20-2.07 (m, 
1H), 2.06-1.89 (m, 2H), 1.88-1.65 (m, 2H). 
13
C NMR 
(75 MHz, CDCl3): diastereomer OHax: $ 170.5, 134.2, 
132.6, 128.8, 126.6, 126.5, 126.1, 125.8, 125.3, 120.9, 
119.3, 78.7, 54.9, 53.2, 38.9, 26.4, 25.9, 18.7, 
diastereomer OHeq: # 217.6, 170.3, 134.2, 132.5, 
128.8, 126.6, 126.5, 126.1, 125.8, 125.3, 120.7, 119.4, 
74.8, 55.2, 54.4, 35.9, 27.6, 26.8, 15.6. MS (ES
+
): m/z 
[(M+Na)
+
] 332; HRMS (ES+): m/z calcd for 
[(C19H19NO3+H)
+
]: 310.1438; found: 310.1443. 
 
11d: this product was synthesized starting from 4d (R 
= Ts, 56 mg, 0.2 mmol) by adapting the above 
procedure. After addition of DBU, the reaction 
mixture was heated at 60 °C for 6 hours to afford 11d 
as a 1:1 mixture of diastereomers as a viscous liquid 
(33 mg, 49%). Rf (EA/CH2Cl2, 2:3) = 0.55; Chiral 
HPLC (Chiralpak IC, hexane/iPrOH/TFA = 7:3:0.01, 
flow rate = 1.0 mL/min, # = 254 nm): diastereomer 
OHax: tminor = 45.6 min, tmajor = 48.3 min, er = 66:1, 
diastereomer OHeq: tminor = 26.6 min, tmajor = 32.6 min, 
er = 14:1; 
1
H NMR (400 MHz, CDCl3): diastereomer 
OHax: # 10.23 (s, NH), 7.93 (d, J = 8.4, 2H), 7.31 (d, J 
= 8.4 Hz, 2H), 4.36 (d, J = 1.7 Hz, 1H), 2.60 (dd, J = 
6.9, 5.5 Hz, 1H), 2.42 (s, 3H), 2.35-2.26 (m, 1H), 
2.15-1.98 (m, 4H), 1.92-1.64 (m, 3H), diastereomer 
OHeq: # 10.12 (s, NH), 7.93 (d, J = 8.4, 2H), 7.31 (d, J 
= 8.4 Hz, 2H), 4.10-4.07 (m, 1H), 2.70 (dd, J = 6.9, 
3.2 Hz, 1H), 2.42 (s, 3H), 2.35-2.26 (m, 1H), 2.15-
1.98 (m, 4H), 1.92-1.64 (m, 3H). 
13
C NMR (75 MHz, 
CDCl3): diastereomer OHax: $ 216.0, 169.4, 145.1, 
135.8, 129.7 (2C), 128.5 (2C), 78.2, 55.5, 52.5, 37.9, 
26.4, 25.5, 21.8, 18.6, diastereomer OHeq: # 215.1, 
169.4, 145.2, 135.7, 129.7 (2C), 128.5 (2C), 74.4, 
55.1, 54.5, 35.1, 26.6, 25.4, 21.8, 15.6. HRMS (ES+): 
m/z calcd for [(C16H19NO5S+H)
+
]: 338.1057; found: 
338.1061. 
 
12: a solution of 11d (0.2 mmol, 1 equiv.), and 2-
iodoxybenzoic acid (IBX) (0.4 mmol, 2 equiv) in 
ethyl acetate (1 mL) was refluxed in a sealed tube for 
18 hours. After cooling to room temperature, the 
mixture was filtered through a short pad of Celite
®
 
and was concentrated under reduced pressure to afford 
quantitatively the crude ketone 12, which could not be 
further purified because of its instability on silica gel. 
Rf (EA/PE, 1:3) = 0.22; Chiral HPLC (Chiralpak IC, 
hexane/EtOH/TFA = 8:2:0.01, flow rate = 1.0 
mL/min, # = 254 nm): tmajor = 12.1 min, tminor = 13.9 
min, er = 24:1; 
1
H NMR (400 MHz, CDCl3): # 7.94 
(d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H), 3.35 (d, J 
= 6.8 Hz, 1H), 2.79 (ddd, J = 17.0, 12.6, 9.4 Hz, 1H), 
2.50 (dd, J = 17.0, 6.7 Hz, 1H), 2.45-2.37 (m, 1H), 
2.42 (s, 3H), 2.28-2.10 (m, 3H), 1.97 (ddd, J = 14.3, 
8.0, 3.1 Hz, 1H), 1.84-1.73 (m, 1H). 
13
C NMR (75 
MHz, CDCl3): $ 206.0, 203.5, 168.3, 145.3, 135.5, 
129.7 (2C), 128.5 (2C), 64.9, 56.1, 33.6, 30.4, 26.2, 
21.8, 21.2. MS (ES
+
): m/z [(M+Na)
+
] 358; HRMS 
(ES+): m/z calcd for [(C16H17NO5S+H)
+
]: 336.0900; 
found: 336.0898. 
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